e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Primary care respiratory problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum leptin level may be a predictor of bone mineral loss in patients with chronic obstructive pulmonary disease
G. Wang, B. Mao, T. Q. Li, Z. L. Wang (Chengdu, China)
Source:
Annual Congress 2007 - Primary care respiratory problems
Session:
Primary care respiratory problems
Session type:
Electronic Poster Discussion
Number:
4058
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Wang, B. Mao, T. Q. Li, Z. L. Wang (Chengdu, China). Serum leptin level may be a predictor of bone mineral loss in patients with chronic obstructive pulmonary disease. Eur Respir J 2007; 30: Suppl. 51, 4058
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The effects of serum leptin on bone metabolism in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Loss of bone mineral density in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Primary care management of COPD
Year: 2007
Plasma inflammatory markers associated with bone resorption in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Serum leptin levels in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 259s
Year: 2002
Serum magnesium levels of patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 107s
Year: 2003
Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Bone mineral density changes in male patients with chronic obstructive pulmonary disease: clinical and biochemical variables in correlation with glucocorticoids use
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009
Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Plasma orexin-A level and body composition in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 485s
Year: 2001
Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
Study of bone mineral density, hemogram and their correlations in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Biomarkers to predict decreased bone mineral density in patients with chronic respiratory failure
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Clinical severity of chronic obstructive pulmonary disease is associated with bone mineral density
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Serum levels of leptin and visfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Different data in COPD
Year: 2015
Association between serum leptin, nutritional status and severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008
Serum amyloid A in patients with stable chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Serum levels of undercarboxylated osteocalcin as a biomarker to predict bone mineral density in patients with chronic respiratory diseases
Source: Annual Congress 2010 - Rehabilitation: more than just exercise
Year: 2010
Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept